SmartVascular Dx™ accurately diagnoses clinically significant vascular inflammation associated with clinical conditions such as infections, autoimmune diseases, cancer, COVID-19, and metabolic abnormalities, all of which have an increased risk of heart attack and stroke.

Science-Driven

SmartVascular Dx™ has been developed through a series of longitudinal outcome-based studies with multiple institutions over a 15-year period of collaborative research representing over 40,000 patients.

Independently Validated

SmartVascular DX has been independently validated at the National Institute of Health (NIH) and the National Heart, Lung, and Blood Institute (NHLBI) in the Multi-Ethnic Study of Atherosclerosis (MESA).

Get started today.